BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Peach buds may be far less dormant than scientists once believed. This study shows that vegetative buds in peach do not ...

Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...

A research team has uncovered the genomic basis behind why some vine tea varieties accumulate far more dihydromyricetin than others.

The sequence Met-Glu-His-Phe-Pro-Gly-Pro gives Semax its hybrid nature: the ACTH fragment portion is thought to influence melanocortin-related signaling, while the PGP motif appears to impart ...

Caris AI Insights are proprietary and only available to Caris Life Sciences customers IRVING, Texas, April 8, 2026 ...

Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...

New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® ...

Qlucore, listed on Nasdaq First North, announces the launch of a new Qlucore Insights test (Research Use Only) specifically developed for Acute Myeloid Leukemia (AML). The software-based test delivers ...